Gilead (GILD) CEO Daniel O'Day logs planned stock sales in Form 4 filing

Rhea-AI Filing Summary

Gilead Sciences Chairman & CEO Daniel O'Day reported planned share sales. On 01/28/2026, he sold 5,032 shares of common stock at a weighted average price of $139.5441 and 4,968 shares at $140.2426 in open-market transactions.

These sales were made under a Rule 10b5-1 trading plan adopted on February 28, 2025. After the transactions, O'Day directly owned 556,698 Gilead shares. The first group of sales occurred at prices ranging from $138.99 to $139.97, and the second from $140.00 to $140.57.

Insider Trade Summary

Net Seller: 10,000 shares ($1,398,911)

Net Sell 2 txns

Insider O'Day Daniel Patrick

Role Chairman & CEO

Sold 10,000 shs ($1.40M)

Type	Security	Shares	Price	Value
Sale	Common Stock	5,032	$139.5441	$702K
Sale	Common Stock	4,968	$140.2426	$697K

Holdings After Transaction: Common Stock — 561,666 shares (Direct)

Footnotes (1)

1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. Sale prices for the transactions reported range from $138.99 to $139.97. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Sale prices for the transactions reported range from $140.00 to $140.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Day Daniel Patrick

(Last) (First) (Middle)

333 LAKESIDE DRIVE

(Street)

FOSTER CITY CA 94404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		S(1)		5,032	D	$139.5441(2)	561,666	D
Common Stock	01/28/2026		S(1)		4,968	D	$140.2426(3)	556,698	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.

2. Sale prices for the transactions reported range from $138.99 to $139.97. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

3. Sale prices for the transactions reported range from $140.00 to $140.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Remarks:

	/s/ Edward S. Son by Power of Attorney for Daniel P. O'Day	01/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Gilead (GILD) report for January 28, 2026?

Gilead reported that Chairman & CEO Daniel O'Day sold two blocks of common stock on January 28, 2026. He sold 5,032 shares at $139.5441 and 4,968 shares at $140.2426, both as open-market transactions disclosed in a Form 4.

How many Gilead (GILD) shares does Daniel O'Day own after this Form 4?

After the reported sales, Daniel O'Day directly owns 556,698 shares of Gilead common stock. This figure reflects his beneficial ownership following the two open-market transactions disclosed for January 28, 2026 in the insider trading report.

Were Daniel O'Day’s Gilead (GILD) share sales pre-planned under Rule 10b5-1?

Yes. The report states that the January 28, 2026 transactions were made under a Rule 10b5-1 trading plan. This plan was adopted on February 28, 2025, allowing preset sales to occur automatically according to predetermined instructions.

What price ranges applied to Daniel O'Day’s Gilead (GILD) stock sales?

The first group of sales, totaling 5,032 shares, occurred at prices from $138.99 to $139.97. The second group of 4,968 shares was sold at prices ranging from $140.00 to $140.57, with weighted average prices disclosed for each block.

Is Daniel O'Day’s ownership in Gilead (GILD) direct or indirect after these sales?

The report shows that Daniel O'Day’s 556,698 Gilead shares following the transactions are held as direct ownership. No indirect ownership entities or disclaimers of beneficial ownership are noted in the provided transaction details.